Skip to content
15% off your first order15% off your first order

BPC-157 vs TB-500

BPC-157 is a synthetic sequence derived from a protein found in gastric juice, while TB-500 is a synthetic fragment of thymosin beta-4. Their studied mechanisms differ. Research on BPC-157 centers on angiogenic signaling, including VEGF-associated pathways, and on the integrity of the intestinal lining. TB-500 is described as binding actin monomers and influencing the cytoskeletal assembly involved in cell migration. BPC-157 has been studied for musculoskeletal soft tissue healing, wound healing and gastroprotection, and one small human report examined knee pain. TB-500 has been studied mainly in animal models, such as rat Achilles tendon healing. For both compounds, human safety data are limited.